Please assess the completion status of the following clinical trial:

Trial Title: Ondansetron VS Doxylamine and Pyridoxine in Treating Nausea of Pregnancy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Women who are less than 16 weeks pregnant by last menstrual period or ultrasound~* Greater than 18 years of age~* English speaking~* No significant visual or hearing impairment~* Requesting treatment for nausea associated with pregnancy~Exclusion Criteria:~* If nausea or vomiting preexisted the pregnancy~* Requires hospitalization at the time of initial enrollment~* Already taking anti-emetics to include metoclopramide, ondansetron, doxylamine, pyridoxine, or promethazine~* The patient has an allergy to either study regimen~* If they are unable to return for a follow up visit in 1 week

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 90 Years
- Healthy Volunteers: f

Study Arms:
- Ondansetron (Type: EXPERIMENTAL): study drug
- Doxylamine and Pyridoxine (vitamin B6) (Type: NO_INTERVENTION): other nausea treatment in use

Based on this trial design, predict the completion outcome and termination type (if applicable).